Goldshield H1 profit up 44%, to increase interim dividend

Source: Healthcare Digital

Date :28/11/2008 09:42:53

Goldshield Group plc said on Friday, November 28, half-year revenues increased by 23 percent, after strong growth in its pharmaceutical and consumer health products units.

The UK pharmaceutical and healthcare company said pretax profit for the six months to September 30 rose 44 percent to £9 million on revenues up 23 percent to £50.2 million.

While net cash dropped five percent to £24.9 million, Goldshield said it was increasing its interim dividend by 16 percent to 2.9 pence. This will be paid January 8, 2009, to shareholders on the register as of December 12, 2008, the company said.

Rakesh Patel, Goldshield Chief Executive said he was “encouraged” by the continued progress given that the economic environment is likely to be volatile. “The board is, however, confident in the resilience of our business,” he added.